Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer. - Wikidata - wikimedia - TriplyDB

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

http://www.wikidata.org/entity/Q43910348

about

Vascular Complications of Cancer Chemotherapy Chemotherapy-induced peripheral neurotoxicity: a critical analysis Zebrafish Germ Cell Tumors Cisplatin-Associated Ototoxicity: A Review for the Health Professional Audiological findings in aphasic patients after stroke Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.DNA combing on low-pressure oxygen plasma modified polysilsesquioxane substrates for single-molecule studies Cardiac and cardiovascular toxicity of nonanthracycline anticancer drugs.Amelioration of cisplatin-induced experimental peripheral neuropathy by a small molecule targeting p75 NTR Pain, neuropathic symptoms, and physical and mental well-being in persons with cancer.Growth differentiation factor 15 (GDF-15) plasma levels increase during bleomycin- and cisplatin-based treatment of testicular cancer patients and relate to endothelial damage.Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner.Retinoic acid reduces chemotherapy-induced neuropathy in an animal model and patients with lung cancer.Biology of childhood germ cell tumours, focussing on the significance of microRNAs.Current update of management of clinical stage I non seminomatous germ cell tumors of testis Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention.Cisplatin Analogs Confer Protection against Cyanide Poisoning.Fertility, gonadal and sexual function in survivors of testicular cancer.Doxorubicin induced heart failure: Phenotype and molecular mechanisms.Animal models of cancer pain.Alpha-lipoic acid and frataxin: a new indication for an old antioxidant?Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis.Chemotherapy-related neuropathic symptoms and functional impairment in adult survivors of extracranial solid tumors of childhood: results from the St. Jude Lifetime Cohort Study.Long-Term Effects, Pathophysiological Mechanisms, and Risk Factors of Chemotherapy-Induced Peripheral Neuropathies: A Comprehensive Literature Review.Echocardiography and cardiac biomarkers in patients with non-small cell lung cancer treated with platinum-based chemotherapy Chemotherapy-induced peripheral neuropathies: from clinical relevance to preclinical evidence.Is there a role for carboplatin in the treatment of malignant germ cell tumors? A systematic review of adult and pediatric trials.Emerging trends in understanding chemotherapy-induced peripheral neuropathy.Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.Subjective quality of life and sexual functioning after germ-cell tumour therapy.Treatment-related Cardiovascular Toxicity in Long-term Survivors of Testicular Cancer.Chemotherapy-induced peripheral neuropathy: limitations in current prophylactic/therapeutic strategies and directions for future research.Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis.Exercise and Aerobic Fitness to Reduce Cancer-Related Cardiovascular Toxicity.Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.A histopathological study of nephrotoxicity, hepatoxicity or testicular toxicity: Which one is the first observation as side effect of Cisplatin-induced toxicity in animal model?

P2860

Q26766269-7C5CDEDD-55D0-4581-A5B9-9F5E6C5E825E Q27010318-52B7A985-ECCD-4E08-9ABD-C31C1DCB5263 Q28076597-D64B0CFE-2A2A-4EB8-8421-945B91120419 Q30365226-56C2C7B6-E40A-4570-A739-B2F260564B79 Q30376708-3A11F888-3966-4DCF-B3EA-C835BBBB4784 Q33520336-74768DF2-7A65-492D-A0BF-8D062A1B3C91 Q33744706-1BB9D8FB-724A-40AF-9365-CF1C58163397 Q33780411-6546AB44-ADBF-414B-8BBE-15384504D96F Q33824948-2F5F9E85-596D-4CF8-96A8-447FA8744794 Q34030601-A4096714-1F27-4EBF-96EE-FF41C123ECA1 Q34305250-51E02E0C-1EB5-4824-9117-9EF912189ACE Q34571555-67FCE750-DF1F-4927-AA22-6FACE8A9D2BF Q34717624-BEFC7B75-46C7-4F5C-A5C0-3C7670A1C04B Q34762806-BAA385A3-22F9-4B1B-89EC-2D4A64002D8D Q34973111-DBCF8053-B2FE-4686-BA01-2B14E30098D6 Q35201327-0863629E-BFE9-4562-9CBD-E6FD0DA0A46B Q35210260-4725A59C-7613-4901-AD83-D5DCD5DDDC31 Q35538367-122625DA-E555-40A1-8549-426AF80476EA Q36084071-8F043EC8-8BEE-40F3-81E0-9AC838CB74BB Q36344699-B0367413-5B65-4AEC-A159-F46FBE6C1197 Q36349055-6DA77B7D-7615-4A02-B9B9-C326A23220D8 Q36615076-3E267B8B-6816-40EA-B8A0-81ED2E55AC13 Q36912561-E80F9A38-36D9-4424-BD6D-2D67B9FC1D6C Q37203216-F779684F-6E41-4BFC-BC30-C0A72799FCDC Q37411050-8CF9C301-ED4C-45CC-80D9-9F48FCCB3994 Q37571709-82216667-5E1E-4F5E-BEA3-EFAADC1DFB97 Q37594508-5B1CDFAC-0FD9-4220-8443-1C9E592B74EC Q37662576-BB515333-8CAF-4508-9F05-1372B874115B Q37671456-A1BA35FF-9E7A-4474-A021-81C438F0F375 Q37826427-27A4CE1A-609A-4D33-869D-39E2F59E08E7 Q38043415-62385199-450B-43BA-B7CE-CA28CFEDD7C1 Q38133440-9D514097-4AC1-47AC-AA2D-17E4B22E87B4 Q38426849-8966E9D2-0F81-406A-A8CF-A65183049CCF Q38611050-B5E6DB9D-8E09-4237-B40F-2396B82646A3 Q38663385-D32F4B73-27AE-4AE5-87EA-D22D06DA7C1E Q38735306-9EA863EC-1A17-49CF-BB2E-1A251D380691 Q38786676-02E2B781-76CB-43D5-B6DD-BC5628CAD423 Q38834995-FB0C8FB3-1621-45E7-B07C-39505DD7DCC5 Q39978264-8445CE4C-EE5F-489F-9E93-44965A771A10 Q41861324-24B96316-6143-4E74-BD2F-7AB24723F9E4

P2860

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer.

http://www.wikidata.org/entity/Q43910348

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@en

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@nl

type

label

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@en

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@nl

prefLabel

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@en

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@nl

P1433

Q43910348-4F249EAD-E89A-4859-8A45-D05FE5E8A84E

P1476

Q43910348-6E60213C-C58E-4289-AED7-7F2B20E3AF26

P2093

Q43910348-068BD400-7C3C-48EE-9388-FBC9ECD3D2A8

Q43910348-0B80ED4C-F86E-4FB3-892C-958FBF945ABC

Q43910348-11C3D50B-62FE-4B8E-8E61-1C79FADEC8E3

Q43910348-494F98C8-D82B-40A2-97D2-0F4C115E8937

Q43910348-4CCA35E3-6F26-4467-9E09-4755071113A6

Q43910348-8CF399C4-6646-485A-A62D-D56D0C3E05E4

Q43910348-94EB9F20-124E-4688-AE8B-F67A3FB855B9

Q43910348-A7791B69-2628-4536-B8CD-47518F0EE9E3

Q43910348-C59E3FA9-B3A3-4D40-A73B-C7F1B4CBBA0B

Q43910348-CDA2DB19-8A08-4C03-9576-48CC6915605B

P2860

Q43910348-0684D340-9654-4838-96C9-9A6145037396

Q43910348-136D2F3E-424D-488C-9596-AFC2ABC91B54

Q43910348-1798F5B8-D6B4-4827-9E43-DAEAEF210616

Q43910348-17C1B208-708E-41DA-AB51-51D1F993EC45

Q43910348-1BC933AE-B841-4276-8B32-5B5630434508

Q43910348-2CD7E15E-3160-4C51-A06F-4CCBAF492D24

Q43910348-33F947F8-4FE3-4E35-9118-19CAA94E7B07

Q43910348-35FC9BD3-E222-4DA6-95A7-7CE90DE057E0

Q43910348-404F9721-B4F4-445F-893F-D83CDB3069C9

Q43910348-4389164F-FCFF-479B-80FC-9C15F185BF91

P304

Q43910348-A599EEC8-D817-4F48-B127-B26E8402B5BA

P31

Q43910348-3A62746A-FFD0-4DBA-8B62-27C84180691D

P356

Q43910348-B419E9A7-4594-4B44-BB9D-26BD93613CBE

P433

Q43910348-A2038EB0-E4A5-4A56-AA27-D37F00A4A50E

P478

Q43910348-952E6DA2-58BE-4EB2-9AC6-55980ADAA623

P577

Q43910348-F52CB1C9-48C9-4858-BA3D-B8B98739D13C

P5875

Q43910348-42EE94D9-5106-49B3-9100-E07CBE27817F

P698

Q43910348-F892EB51-EBBB-4AF0-A8F9-20A71F4F4F7E

P921

Q43910348-FE226FC7-D66A-42D6-9775-5BAED6729FA8

P356

P1433

Annals of Oncology

P1476

Evaluation of long-term toxici ...... eminomatous testicular cancer.

@en

P2093

C Möckel

http://www.w3.org/2001/XMLSchema#string

C Reiners

http://www.w3.org/2001/XMLSchema#string

D Strumberg

http://www.w3.org/2001/XMLSchema#string

G Scheiber

http://www.w3.org/2001/XMLSchema#string

J Ranft

http://www.w3.org/2001/XMLSchema#string

M E Scheulen

http://www.w3.org/2001/XMLSchema#string

M W Korn

http://www.w3.org/2001/XMLSchema#string

S Brügge

http://www.w3.org/2001/XMLSchema#string

S Koeppen

http://www.w3.org/2001/XMLSchema#string

S Seeber

http://www.w3.org/2001/XMLSchema#string

P2860

Long-term neurotoxicity in patients treated with cisplatin, vinblastine, and bleomycin for metastatic germ cell cancer

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide.

Treatment of testicular tumours based on risk factors.

Treatment of disseminated non-seminomatous testicular cancer: the European experience.

Guidelines for the diagnosis and therapy of testicular cancer and new developments.

Therapy-related malignancies following treatment of germ cell cancer.

Increase in testicular cancer incidence in six European countries: a birth cohort phenomenon.

Endocrinological late effects after chemotherapy for testicular cancer.

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.

P304

229-236

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDF058

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11477204

http://www.w3.org/2001/XMLSchema#string

P698

11885999

http://www.w3.org/2001/XMLSchema#string

P921